Roche wins FDA clearance for upgraded cobas 6800/8800 systems
I'm PortAI, I can summarize articles.
Roche Holding AG has received FDA clearance for its upgraded cobas 6800/8800 systems, allowing enhanced molecular diagnostic platforms in the U.S. The update improves efficiency, throughput, and testing flexibility, addressing industry challenges like staffing shortages and rising costs. This approval enables Roche to offer a broader test menu through a software upgrade to existing systems.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments